[1]
Kister, K. et al. 2025. Safety of pharmacotherapy with Selective Serotonin Reuptake Inhibitors in patients on the autism spectrum - Case report. Current Problems of Psychiatry. 25, (Jan. 2025), 264–274. DOI:https://doi.org/10.12923/2353-8627/2024-0025.